Literature DB >> 22609583

Adsorption and desorption of doxorubicin on oxidized carbon nanotubes.

Yunxia Wang1, Sheng-Tao Yang, Yanli Wang, Yuanfang Liu, Haifang Wang.   

Abstract

Carbon nanotubes (CNTs) show promise as nano-drug carriers. To develop the CNT-based drug delivery systems, drug loading and release are two major issues. In this study, we systematically evaluated the adsorption and desorption of doxorubicin (DOX) on oxidized multi-walled CNTs (O-MWCNTs). Our results indicated that O-MWCNTs possessed a huge adsorption capacity for DOX (9.45×10(3) mg/g). Although the adsorption process was quite slow, the adsorption capacity kept high enough for the therapy while shortening the incubation time to 2h (1.03×10(3) mg/g). The desorption of DOX from O-MWCNTs scarcely occurred while incubated in buffer solution at both pH 7.4 and pH 5.5, however, the lower pH did benefit the desorption. The presence of serum proteins facilitated the desorption of DOX significantly, because these proteins bound strongly to O-MWCNTs resulting in the partial surface of O-MWNCTs being occupied. Moreover, the adsorption time also affected the release of DOX from O-MWCNTs. Shortening the incubation time benefited the release of DOX. The implications to the drug loading and therapeutics of the CNT-based drug delivery systems are discussed.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609583     DOI: 10.1016/j.colsurfb.2012.04.013

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

1.  A large-inner-diameter multi-walled carbon nanotube-based dual-drug delivery system with pH-sensitive release properties.

Authors:  Tao Yang; Zhenzhen Wu; Pingting Wang; Tingting Mu; Han Qin; Zhimin Zhu; Jian Wang; Lei Sui
Journal:  J Mater Sci Mater Med       Date:  2017-06-06       Impact factor: 3.896

2.  Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers.

Authors:  Darren C Wu; Clyde M Ofner
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

3.  PEGylated single-walled carbon nanotubes as nanocarriers for cyclosporin A delivery.

Authors:  Naghmeh Hadidi; Farzad Kobarfard; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  AAPS PharmSciTech       Date:  2013-03-12       Impact factor: 3.246

4.  Pharmacodynamic Studies of Fluorescent Diamond Carriers of Doxorubicin in Liver Cancer Cells and Colorectal Cancer Organoids.

Authors:  Ron Firestein; Cezary Marcinkiewicz; Linyan Nie; Hui Kheng Chua; Ines Velazquez Quesada; Marco Torelli; Mark Sternberg; Bojana Gligorijevic; Olga Shenderova; Romana Schirhagl; Giora Z Feuerstein
Journal:  Nanotechnol Sci Appl       Date:  2021-09-07

5.  Description of Release Process of Doxorubicin from Modified Carbon Nanotubes.

Authors:  Dorota Chudoba; Monika Jażdżewska; Katarzyna Łudzik; Sebastian Wołoszczuk; Ewa Juszyńska-Gałązka; Mikołaj Kościński
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

6.  Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.

Authors:  Yu-Jen Lu; Pin-Yi Lin; Pei-Han Huang; Chang-Yi Kuo; K T Shalumon; Mao-Yu Chen; Jyh-Ping Chen
Journal:  Nanomaterials (Basel)       Date:  2018-03-27       Impact factor: 5.076

7.  Kinetic and Equilibrium Studies of Doxorubicin Adsorption onto Carbon Nanotubes.

Authors:  Dorota Chudoba; Katarzyna Łudzik; Monika Jażdżewska; Sebastian Wołoszczuk
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

8.  Multi-Walled Carbon Nanotubes Decorated with Guanidinylated Dendritic Molecular Transporters: An Efficient Platform for the Selective Anticancer Activity of Doxorubicin.

Authors:  Kyriaki-Marina Lyra; Archontia Kaminari; Katerina N Panagiotaki; Konstantinos Spyrou; Sergios Papageorgiou; Elias Sakellis; Fotios K Katsaros; Zili Sideratou
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.